About the Study | How Does This Affect You?

Cognitive decline is a loss of memory, intellectual, and social skills. It can lead to a loss of independent function and disability. The decline can be caused by a number of reasons. Some researchers have suggested that high levels of homocysteine in the blood may contribute to the loss. But B vitamins, found in foods or supplements, are believed to reduce homocysteine levels in the blood.

The Women’s Antioxidant and Folic Acid Cardiovascular Study is a large trial designed to study the benefits of B vitamins and folic acid against heart disease. Researchers from Channing Laboratory used information from this study as a basis to also study cognitive decline in women. The study, published in the American Journal of Clinical Nutrition, found that B vitamin supplementation did not delay cognitive impairment.

About the Study

The Women’s Antioxidant and Folic Acid Cardiovascular Study is a randomized controlled trial. It has followed a select group of women since 1998. Some of the participants were randomly assigned to receive B vitamins, while others received a placebo. Researchers began to measure cognitive function in 2,009 of the participants. Cognitive function was measured through a telephone test given four times over a five-year period. The test evaluated:

  • General cognition—thought process
  • Verbal memory—memory of spoken words
  • Category fluency—a memory test that also involves placing words into categories

The results did not show a significant difference in cognitive decline between the women taking supplements and the women taking a placebo.

Some evidence, however, suggested that women who had low dietary vitamin B may have had some protection against cognitive decline with the supplement.